Tocqueville Asset Management L.P. Makes New Investment in Viemed Healthcare, Inc. $VMD

Tocqueville Asset Management L.P. purchased a new position in Viemed Healthcare, Inc. (NASDAQ:VMD) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 342,100 shares of the company’s stock, valued at approximately $3,900,000.

Several other hedge funds also recently made changes to their positions in the stock. State of Alaska Department of Revenue purchased a new stake in Viemed Healthcare during the 4th quarter worth about $25,000. Kemnay Advisory Services Inc. bought a new stake in shares of Viemed Healthcare during the fourth quarter valued at about $46,000. Quarry LP bought a new stake in shares of Viemed Healthcare during the third quarter valued at about $48,000. AQR Capital Management LLC bought a new stake in shares of Viemed Healthcare during the first quarter valued at about $90,000. Finally, R Squared Ltd purchased a new stake in shares of Viemed Healthcare in the fourth quarter worth about $102,000. 74.24% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several brokerages recently commented on VMD. Weiss Ratings cut shares of Viemed Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Monday. Wall Street Zen cut shares of Viemed Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 15th. Finally, Freedom Capital downgraded shares of Viemed Healthcare from a “strong-buy” rating to a “hold” rating in a report on Wednesday, August 5th. Three analysts have rated the stock with a Hold rating, According to data from MarketBeat, Viemed Healthcare has an average rating of “Hold”.

Insiders Place Their Bets

In other Viemed Healthcare news, insider William Frazier sold 10,000 shares of the company’s stock in a transaction dated Thursday, June 25th. The shares were sold at an average price of $11.72, for a total transaction of $117,200.00. Following the completion of the sale, the insider directly owned 73,214 shares in the company, valued at $858,068.08. This represents a 12.02% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Timothy Smokoff sold 20,000 shares of the firm’s stock in a transaction dated Wednesday, June 24th. The shares were sold at an average price of $11.50, for a total value of $230,000.00. Following the transaction, the director directly owned 75,518 shares in the company, valued at $868,457. This trade represents a 20.94% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 20.60% of the stock is owned by company insiders.

Viemed Healthcare Trading Down 4.1%

VMD stock opened at $8.57 on Friday. The company has a market capitalization of $326.43 million, a PE ratio of 23.81 and a beta of 1.10. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.02 and a current ratio of 1.13. Viemed Healthcare, Inc. has a one year low of $6.05 and a one year high of $12.61. The company’s 50 day moving average price is $11.01 and its two-hundred day moving average price is $9.87.

Viemed Healthcare (NASDAQ:VMD) last announced its quarterly earnings data on Monday, August 3rd. The company reported $0.07 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.05). Viemed Healthcare had a net margin of 4.81% and a return on equity of 10.16%. The business had revenue of $78.10 million during the quarter, compared to analysts’ expectations of $78.00 million. As a group, analysts predict that Viemed Healthcare, Inc. will post 0.42 earnings per share for the current fiscal year.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.